Graph: Figure 1 Circulating dipeptidyl peptidase 3 (cDPP3) was identified as a novel marker of cardiogenic shock (CS) and increased mortality risk in patients with acute coronary syndromes (ACS). Eur Heart J 2023; 44: 3859 - 71. https://doi.org/10.1093/eurheart...
2023 ESC Guidelines for the management of acute coronary syndromes (ACS) 总述 急性期治疗 抗栓治疗 心脏骤停、心源性休克 血管重建治疗 其他 Contents “5 think” “working diagnosis” vs. “final diagnosis” STEMI STEMI:没有太多变化 STEMI STEMI P2Y12i预处理: I A – IIb B DUBIUS trial NSTEMI...
Dr. Ibanez said, "One of the key aims of these Guidelines is to highlight that acute coronary syndromes encompass a spectrum of conditions. Some patients have mild symptoms while others become critically ill very quickly. Despite this, much of the management follows the same principles, and thi...
2015AHA心肺复苏指南:Part 9 Acute Coronary Syndromes S483IntroductionClinicians often struggle with uncertainty and complexity in deciding which course of treatment will likely lead to an opti-mal outcome for an individual patient. Scientific research pro-vides information on how patient populations have ...
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationRoffiM.PatronoC.ColletJ.P.MuellerValgimigliAndreottiingentaconnectEuropean Heart Journal
acute coronary syndrome(redirected from Acute coronary syndromes)Also found in: Acronyms. acute [ah-kūt´] 1. sharp. 2. having severe symptoms and a short course. Some serious illnesses that were formerly considered acute (such as myocardial infarction) are now recognized to be acute ...
eight different clinical scenarios concerning the use of: aspirin, clopidogrel, beta blockers, calcium channel blockers, ACE inhibitors, statin therapy, early invasive strategy in high risk non-ST-elevation acute coronary syndromes (NSTEACS), and reperfusion therapy (Physician Guidelines Study Question...
Second, the benefit of the CCP was not limited to suburban or non-tertiary institutions with low adherence to clinical guidelines, but also applied to a coronary care unit of a major academic institution with an averaged baseline adherence to evidence-based therapies. Third, implementation of the...
your practice thanks to new chapters on biomarkers in acute ischemic heart disease; the role of noninvasive testing in prognostic risk stratification; the culprit lesions and patient at risk; non-responsiveness to antiplatelet therapy; bleeding in the acute coronary syndromes; and the refractor...